Welsh startup Amotio has raised 拢810,000 ($1.1m) to advance its technology for improving outcomes during orthopaedic revision surgery.
The company鈥檚 first major pre-seed funding round was led by a 拢500,000 ($682,000) investment from the Development Bank of Wales, with additional backing from European investment firm NLC Health Ventures and Orthopaedic Research UK.
Implant fixation takes the approach of uncemented fixation, where an implant is anchored to the bone, or cemented, where an implant is fixed using a compound made of Polymethyl Methacrylate (PMMA).
However, research from the UK indicates that around due to issues such as implant failure, infection, loosening, or bone fractures.
Amotio worked with biomechanical engineers from University Medical Center Utrecht to develop a solution for removing bone cement during hip revision surgery. The technology uses advanced digital joint mapping, 3D printing, and precision tools. Starting with a patient鈥檚 CT scan, the system allows surgeons to collaborate with Amotio to create the surgical plan, including a custom-made guide and a specialised device for safe bone cement removal.
Through early-stage investment and non-dilutive funding, Amotio has now raised around 拢1.6m ($2.1m), which will support the company鈥檚 ongoing R&D and eventually help it progress to pre-clinical testing and regulatory approval for the technology.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAmotio鈥檚 eventual expectation is to expand its technology for use in all major joint surgeries for patients in global markets including the US, Europe, and the Asia-Pacific.
Amotio CEO Iestyn Foster commented: 鈥淚n current financial conditions it is extremely difficult as a medtech start-up to attract initial early stage investment, but with the support of our co-founder and investor NLC Health Ventures, specialist venture funds from ORUK, and the Development Bank of Wales, they have all understood the complex needs of our business and the impact our solution will make, along with our ambitions for future growth.鈥�
In the US, major joint replacement surgeries among those aged 50 and above are projected to reach .
